Biotech Company Grabs 180K SF At Menlo Park Labs

Courtesy of Tarlton Properties
Pacific Biosciences Of California's New Headquarters At Menlo Park Labs

Pacific Biosciences of California has moved into a 180K SF headquarters at Tarlton Properties’ Menlo Park Labs. The biotech company has leased 1305 O’Brien Drive through 2027. The company originally started with 10K SF.

The new structure, which underwent a massive transformation after its time as an OfficeMax distribution facility, features a two-story lobby, an exterior amenities space, extensive research labs, manufacturing floor space and a conference center. It shares various amenities with the 50-acre Menlo Park Labs, which offers a commuter shuttle, bike sharing, EV car chargers, a restaurant, a fitness center and tennis and volleyball courts.

The opening of PacBio's new building comes on the heels of Refuge Biotechnologies and AccuraGen moving into Menlo Park Labs three months ago. More than 60 biotech, medical device and life science companies occupy the campus.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Jose Newsletters
Related Stories

Taiwan Semiconductor Manufacturing Co. Could Expand In North Texas

Morningstar Releases New Details On Over 350K SF In Q3 Office Leases

Weil Gotshal Wind-Down Leaves 830K SF Hole In America's Office Market

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

EXCLUSIVE: Downtown Houston+ Targets Grocery Gap, Pedestrian Experience With New Programs

Office Recovery Moving Faster Than Expected, CoStar Finds

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

How Microsoft, Coca-Cola And Amazon Are Adapting Their Offices For AI Age

Hof Wonen Acquires 251 Social Rental Houses In New Mixed-Use Project In The Hague

Related, Oxford Land Tenant For Top Floors Of 70 Hudson Yards

BXP Execs See Better Returns In Building Offices Than Buying Them

Downtown Office Tower Sells At Foreclosure Auction For $260M